Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29

May 22, 2024 4:35 PM

Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29 in Minneapolis.The conference is a multi-industry event featuring more than 130...

Read more

Report from the Annual General Meeting 2024 of IRLAB Therapeutics AB

May 22, 2024 1:00 PM

GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Today, on Wednesday May 22, 2024, IRLAB Therapeutics AB held its Annual General Meeting.The following main resolutions were made upon at the Annual General Meeting.Adoption of income statement and balance sheet as well as consolidated income statement and consolidated balance sheetThe Annual General Meeting adopted the income statement and the...

Read more

Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries

May 22, 2024 11:15 AM

Bristol Myers Squibb (NYSE:BMY) today announced ASPIRE (Accessibility, Sustainability, Patient-centric, Impact, Responsibility and Equity), a 10-year strategy to advance access to our innovative treatments and help patients in low- and middle-income countries (LMICs) gain access to potentially life-saving medicines. This strategy supports the company's commitment to reach more than 200,000 patients in LMICs by 2033 with its innovative...

Read more

HealthJoy Celebrates 10 Years of Bringing Benefits to Life

May 22, 2024 10:30 AM

Care navigation platform celebrates a decade of amplifying benefit strategies to help employers contain costs and improve health outcomesCHICAGO, IL / ACCESSWIRE / May 22, 2024 / HealthJoy, a care navigation platform that transforms healthcare outcomes by reimagining benefits, recently celebrated its 10-year anniversary. With over $100M in fundraising to date, HealthJoy gives HR leaders, CFOs and benefit consultants the platform needed to...

Read more

Enzolytics, Inc. Announces Letter of Intent for Exclusive Licensing Agreement for Patented Nitric Oxide Formulation

May 22, 2024 10:15 AM

Updates on ETC Marketing, Inc and Ownership of ITV-1 and IPFALLEN, TX / ACCESSWIRE / May 22, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com")(the "Company") announced today that it has entered into a Letter of Intent with Enogenesis (ENGN) for the specific use of the therapeutic application of ENGN's patented Nitric Oxide Compound ( "NOC"). The initial focus for sales will be combining NOC with the nutraceutical products of the wholly...

Read more

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market

May 22, 2024 9:05 AM

Laxxon Medical announced today the development program for LXM.2, a 3D printed oral glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of adults and pediatric patients 12 years and older with obesity.LXM.2 is an enterically coated oral solid tablet consisting of a GLP-1 receptor agonist combined with a permeation enhancer intended to increase bioavailability. The addition of the permeation enhancer was made possible using Laxxon...

Read more

Assured Allies Announces a Multi-Year Partnership to Support CalPERS Long-Term Care Policyholders in Maintaining Their Independence

May 22, 2024 9:00 AM

BOSTON, MA / ACCESSWIRE / May 22, 2024 / Assured Allies, the leading insurtech company for evidence-based successful aging, today announced the launch of an AgeAssured pre-claim wellness program that will serve CalPERS long-term care policyholders.The AgeAssured program will be offered at no cost to eligible CalPERS long-term care policyholders, for a period of at least 5 years. CalPERS policyholders who are 75 and older and not on claim, will...

Read more

Halberd/Athena GTX Research Promises a Much Brighter Future

May 22, 2024 8:00 AM

Walt Disney once said, "All our dreams can come true if we have the courage to pursue them".JACKSON CENTER, PA / ACCESSWIRE / May 22, 2024 / Halberd Corporation (OTC PINK:HALB) in cooperation with Athena GTX, Inc is standing at the threshold of some major advancements to treat the issues facing not only our military but people around the world. In essence, the traumas of depression, anxiety, substance use disorders, and suicidal ideation can...

Read more

Sonnet BioTherapeutics Announces Review of Strategic Alternatives

May 22, 2024 7:00 AM

PRINCETON, NJ / ACCESSWIRE / May 22, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that its Board of Directors has initiated a process to explore and review a range of strategic alternatives focused on maximizing stockholder value.Sonnet has engaged Chardan Capital Markets, LLC ("Chardan") to act as its financial...

Read more

Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting

May 22, 2024 7:00 AM

Moderna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDTCAMBRIDGE, MA / ACCESSWIRE / May 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on mRNA-4157 (V940), an investigational mRNA individualized neoantigen therapy, have been accepted for presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 31 - June 4 in Chicago, IL. mRNA-4157 (V940) is...

Read more

IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757

May 22, 2024 6:50 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 22, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that dosing has been initiated in a Phase I study of the drug candidate IRL757. IRL757 has been shown in preclinical disease models to counteract apathy - a condition that...

Read more

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

May 22, 2024 6:00 AM

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has granted approval for the Company's Abbreviated New Drug Application ("ANDA") for Albuterol Sulfate Inhalation Aerosol, previously known as AMP-008. This product is for the treatment or prevention of bronchospasm in patients four years of age and older with reversible obstructive...

Read more

Evotec Reports Q1 2024 Results and Provides Corporate Update

May 22, 2024 1:30 AM

CHALLENGING Q1 WITH SOFTNESS MAINLY IN TRANSACTIONAL/DEVELOPMENT SHARED R&D BUSINESS AGAINST A STRONG COMPARABLE QUARTERSTRONG START WITH JUST - EVOTEC BIOLOGICS IN Q1 2024POSITIVE MOMENTUM IN SHARED R&D DISCOVERY CLOSED SALES POINT TO RECOVERY OF REVENUES TOWARDS END OF THE YEARRESET FOR PROFITABLE GROWTH INITIATED, NEW REPORTING SEGMENTS INTRODUCED: SHARED R&D AND JUST - EVOTEC BIOLOGICSHAMBURG, GERMANY / ACCESSWIRE / May 22, 2024 / Evotec SE...

Read more

IRLAB Broadcasts the Annual General Meeting Live

May 22, 2024 1:20 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 22, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company's annual general meeting will be broadcast live on YouTube.The broadcast will take place provided that a decision to broadcast the meeting is made by the...

Read more

Ruth Clements Speaks at National Action Network Event Addressing Health Inequities

May 21, 2024 3:15 PM

NORTHAMPTON, MA / ACCESSWIRE / May 21, 2024 / Quest Diagnostics East Region President Ruth Clements explained how routine diagnostic testing is crucial to closing gaps in healthcare as part of health panel at the National Action Network (NAN) Convention in April.Hosted by Choose Healthy Life (CHL), Ruth joined "The State of Black Health: Building a New Normal," to discuss the gap in care for the black community. The panel was moderated by Choose...

Read more

Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30

May 21, 2024 3:01 PM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.Company WebcastThe Company's...

Read more

New Clinical Study Published in Anesthesiology Confirms the Leading Accuracy and Precision of Senzime's TetraGraph System

May 21, 2024 3:00 PM

UPPSALA, SWEDEN / ACCESSWIRE / May 21, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) In a new clinical study published in the high-impact Anesthesiology journal, a team of US-based researchers compared the accuracy and precision of commercially available neuromuscular block monitors. The study confirms the leading accuracy and precision of Senzime's TetraGraph system, which produced results similar to a gold-standard laboratory reference, while the...

Read more

Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30

May 21, 2024 2:07 PM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.Company WebcastThe Company's...

Read more

Lab Week 2024 - Deepika Kumar

May 21, 2024 1:15 PM

NORTHAMPTON, MA / ACCESSWIRE / May 21, 2024 / Quest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professionals and pathologists. As part of the celebration, we also featured highlights of the professional journeys of Quest colleagues from across the country.---From Lab Assistant to Associate Scientist11 years at QuestSouthwest Region - Lewisville, Texas Q: What did you...

Read more

Sound Physicians Announces Transformative Transaction to Increase Liquidity and Financial Flexibility; Aims to Drive Growth as the Physician Services Partner of Choice

May 21, 2024 12:15 PM

Proactively bolsters liquidity with comprehensive debt restructuring and $124 million of new capital; Enters into transaction with overwhelming majority of key partners in capital structure; Momentum follows recent leadership appointments as Company builds a world-class leadership team across key disciplines to advance strategic initiatives.NEW YORK, NY / ACCESSWIRE / May 21, 2024 / Sound Physicians (the "Company"), a leading provider of...

Read more